Literature DB >> 17932680

Upper and lower gastrointestinal diseases in liver transplant candidates.

G Gravante1, D Delogu, D Venditti.   

Abstract

BACKGROUND: The incidence and risk factors of gastrointestinal diseases in pre-liver transplant population are still a matter of debate. In a retrospective analysis, we addressed two questions: (1) Are there any lesions that occur at a higher prevalence than in the general population, and (2) are there patient characteristics that could predict their presence?
MATERIALS AND METHODS: All asymptomatic patients that successfully entered the waiting list of liver transplantation were recorded. We also compared results with those obtained from a control group of non-cirrhotic patients undergoing screening for colorectal cancer. Main outcome measures were the incidence and description of upper/lower gastrointestinal findings after screening endoscopic examination.
RESULTS: We retrospectively evaluated from April 2004 to July 2007 a total of 80 liver transplant candidates. The most frequent pathologies were esophageal varices (71.2% of subjects), portal hypertensive gastropathy (51.2%), hemorrhoids (22.5%), and colonic polyps (18.7%). Comparison with 80 non-cirrhotic patients matched for age and sex demonstrated an increased frequency in the cirrhotic group of ulcerative colitis (6.2 vs 0%; p = 0.02) and portal hypertensive colopathy (12.5 vs 0%; p = 0.001) in non-cirrhotic of diverticulosis (10 vs 25%; p = 0.01) and hemorrhoids (22.5 vs 40%; p = 0.02). The univariate analysis showed no significant correlation between colonic polyps and patients' variables, except a mild correlation with age not confirmed at the multivariate analysis.
CONCLUSIONS: The incidence of some benign gastrointestinal pathologies in liver transplant candidates is different from the asymptomatic population but not that of colorectal cancer or colonic polyps.

Entities:  

Mesh:

Year:  2007        PMID: 17932680     DOI: 10.1007/s00384-007-0386-8

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  24 in total

Review 1.  Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990.

Authors:  R de Franchis; J P Pascal; E Ancona; A K Burroughs; M Henderson; W Fleig; R Groszmann; J Bosch; T Sauerbruch; C Soederlund
Journal:  J Hepatol       Date:  1992-05       Impact factor: 25.083

Review 2.  Factors which influence the incidence and course of peptic ulcer.

Authors:  A Sonnenberg
Journal:  Scand J Gastroenterol Suppl       Date:  1988

3.  Prevalence and factors influencing hemorrhoids, anorectal varices, and colopathy in patients with portal hypertension.

Authors:  S P Misra; M Dwivedi; V Misra
Journal:  Endoscopy       Date:  1996-05       Impact factor: 10.093

4.  Prevalence of endoscopic findings in 510 consecutive individuals with cirrhosis evaluated prospectively.

Authors:  M Rabinovitz; Y K Yoo; R R Schade; V J Dindzans; D H Van Thiel; J S Gavaler
Journal:  Dig Dis Sci       Date:  1990-06       Impact factor: 3.199

5.  Colonic diverticulosis in Hong Kong: distribution pattern and clinical significance.

Authors:  C C Chan; K K Lo; E C Chung; S S Lo; T Y Hon
Journal:  Clin Radiol       Date:  1998-11       Impact factor: 2.350

6.  Frequency of upper gastrointestinal lesions in patients with liver cirrhosis.

Authors:  C Sacchetti; M Capello; P Rebecchi; L Roncucci; G Zanghieri; A Tripodi; M Ponz de Leon
Journal:  Dig Dis Sci       Date:  1988-10       Impact factor: 3.199

7.  Angiodysplasia in the colon and rectum. Endoscopic morphology, localisation and frequency.

Authors:  W Höchter; J Weingart; W Kühner; E Frimberger; R Ottenjann
Journal:  Endoscopy       Date:  1985-09       Impact factor: 10.093

8.  Portacaval anastomosis and peptic ulcer: a nonassociation.

Authors:  M M Phillips; G R Ramsey; H O Conn
Journal:  Gastroenterology       Date:  1975-01       Impact factor: 22.682

9.  Prophylactic endoscopic sclerosing treatment of the esophageal wall in varices -- a prospective controlled randomized trial.

Authors:  K J Paquet
Journal:  Endoscopy       Date:  1982-01       Impact factor: 10.093

10.  Peptic ulcer in hepatic cirrhosis and renal failure.

Authors:  J Y Kang
Journal:  J Gastroenterol Hepatol       Date:  1994       Impact factor: 4.029

View more
  3 in total

1.  Portal hypertensive gastropathy: A systematic review of the pathophysiology, clinical presentation, natural history and therapy.

Authors:  Mihajlo Gjeorgjievski; Mitchell S Cappell
Journal:  World J Hepatol       Date:  2016-02-08

2.  Portal Hypertensive Polyposis in Advanced Liver Cirrhosis: The Unknown Entity?

Authors:  David Kara; Anna Hüsing-Kabar; Hartmut Schmidt; Inga Grünewald; Gursimran Chandhok; Miriam Maschmeier; Iyad Kabar
Journal:  Can J Gastroenterol Hepatol       Date:  2018-08-01

3.  Chronic liver disease promotes lesions of the colorectal adenoma-carcinoma sequence, independent of liver cirrhosis.

Authors:  Amelie S Troschel; Alexander Miks; Fabian M Troschel; Anna Hüsing-Kabar; Miriam Maschmeier; Hauke S Heinzow; Hartmut H Schmidt; Iyad Kabar
Journal:  United European Gastroenterol J       Date:  2019-01-21       Impact factor: 4.623

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.